Genomic analysis approach to avoid from complications from proton pump inhibitor and warfarin combination therapy after open heart surgery

Genomic analysis approach to avoid from complications from proton pump inhibitor and warfarin combination therapy after open heart surgery - Genomic analysis for order made prescription after open heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007826

Enrollment

120

Registered

2012-04-30

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic heart disease, heart valve disease, atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: must be administrated warfarin and proton pump inhibitor after open heart surgery

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
INR value is 3.5 or more. INR value is 1.5 below even if administrated 5mg of warfarin occurring bleeding event occurring thromboembolic event	—

Countries

Japan

Contacts

Public ContactKimura Haruka

Nihon university school of medicine Cardiovascular surgery

permanentfixture@gmail.com03-3972-8111

Outcome results